Drug screening--beyond the bottleneck.
High-throughput screening still has a long way to go if it is to achieve its often-touted potential.
Dove
A
A
D003132:Commerce; D004353:Drug Evaluation, Preclinical / Q000191:economics / Q000295:instrumentation*; D004345:Drug Industry / Q000191:economics / Q000295:instrumentation*; D020411:Oligonucleotide Array Sequence Analysis; D013678:Technology, Pharmaceutical / Q000191:economics / Q000295:instrumentation*